Alumis, Inc. (ALMS)
23.62
+0.58
(+2.54%)
USD |
NASDAQ |
Aug 25, 12:20
Alumis 1 Year Total Returns (Daily) : 375.8% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 375.8% |
| August 21, 2026 | 425.4% |
| August 20, 2026 | 418.4% |
| August 19, 2026 | 407.2% |
| August 18, 2026 | 413.0% |
| August 17, 2026 | 436.8% |
| August 14, 2026 | 476.5% |
| August 13, 2026 | 452.3% |
| August 12, 2026 | 472.9% |
| August 11, 2026 | 484.6% |
| August 10, 2026 | 540.2% |
| August 07, 2026 | 537.4% |
| August 06, 2026 | 536.2% |
| August 05, 2026 | 545.7% |
| August 04, 2026 | 563.1% |
| August 03, 2026 | 532.4% |
| July 31, 2026 | 582.4% |
| July 30, 2026 | 606.1% |
| July 29, 2026 | 567.8% |
| July 28, 2026 | 569.1% |
| July 27, 2026 | 597.9% |
| July 24, 2026 | 625.4% |
| July 23, 2026 | 637.0% |
| July 22, 2026 | 770.4% |
| July 21, 2026 | 805.1% |
| Date | Value |
|---|---|
| July 20, 2026 | 740.2% |
| July 17, 2026 | 716.5% |
| July 16, 2026 | 691.6% |
| July 15, 2026 | 725.5% |
| July 14, 2026 | 657.8% |
| July 13, 2026 | 698.3% |
| July 10, 2026 | 695.2% |
| July 09, 2026 | 765.7% |
| July 08, 2026 | 754.6% |
| July 07, 2026 | 784.3% |
| July 06, 2026 | 702.1% |
| July 02, 2026 | 707.9% |
| July 01, 2026 | 782.1% |
| June 30, 2026 | 838.0% |
| June 29, 2026 | 798.7% |
| June 26, 2026 | 700.0% |
| June 25, 2026 | 754.3% |
| June 24, 2026 | 725.6% |
| June 23, 2026 | 775.4% |
| June 22, 2026 | 760.1% |
| June 18, 2026 | 677.7% |
| June 17, 2026 | 665.8% |
| June 16, 2026 | 613.1% |
| June 15, 2026 | 632.5% |
| June 12, 2026 | 659.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Corcept Therapeutics, Inc. | 75.23% |
| Aclaris Therapeutics, Inc. | 250.6% |
| Crinetics Pharmaceuticals, Inc. | 174.2% |
| Tarsus Pharmaceuticals, Inc. | 27.18% |
| Structure Therapeutics, Inc. | 149.9% |